Congressional Prediction Market Ban Act of 2026
HB8838, titled the Congressional Prediction Market Ban Act of 2026, would amend chapter 131 of title 5 of the U.S. Code to bar Members of Congress from participating in prediction markets. The bill defines a covered transaction broadly to include buying, selling, exchanging, or otherwise benefiting from prediction market contracts tied to the occurrence or nonoccurrence of specific events or contingencies, while excluding ordinary insurance contracts with a lawful insurable interest.
The bill also extends the prohibition to situations where a Member benefits through a household member’s participation in a covered transaction. Members of the House and Senate would be required to certify annually that they complied with the ban during the prior calendar year, and those certifications would be posted publicly by the Clerk of the House and Secretary of the Senate. Congressional ethics committees would be required to investigate noncompliance or credible reports of violations, and could impose or recommend additional sanctions under chamber rules.
If enacted, the bill would add a new subchapter to title 5 governing congressional ethics and financial conduct, creating a specific statutory prohibition on Members of Congress engaging in prediction markets. It would also impose new compliance, disclosure, and enforcement duties on the House and Senate ethics committees, including public reporting of annual certifications and investigation of alleged violations. Violations could result in fines of at least $10,000 or triple the profit from the violation, with proceeds deposited into the Treasury.
Based on the bill text and the absence of recorded votes or committee debate, the measure appears to be framed as an ethics and conflict-of-interest reform aimed at preventing lawmakers from profiting from event-based speculative markets. The structure of the bill suggests a strong anti-corruption or public-trust rationale, with emphasis on transparency, enforcement, and deterrence. No contrary views are documented in the provided materials, so the available record does not show organized support or opposition beyond the bill’s introduction and referral.
The main policy issue is the scope of the ban: the bill reaches not only direct participation by Members of Congress but also indirect benefits through household members, which could raise questions about overbreadth and enforceability. Another potential point of contention is the definition of “prediction market contract,” which is broad and tied to Commodity Exchange Act concepts, potentially implicating emerging financial products and event-based trading platforms. Enforcement authority is also notable, because the bill relies on congressional ethics committees to investigate and sanction violations, leaving room for debate over whether internal congressional discipline is sufficient or whether stronger external enforcement would be needed.